Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.
Leyre ZubiriGabriel E MolinaMeghan J MooradianJustine CohenSienna M DurbinLaura PetrilloGenevieve M BolandDejan JuricMichael L DouganMolly F ThomasAlex T FajeMichelle RengarajanAmanda C GuidonSteven T ChenDaniel OkinBenjamin D MedoffMazen NasrallahMinna J KohlerSara R SchoenfeldRebecca S Karp-LeafMeghan E SiseTomas G NeilanDaniel A ZlotoffJocelyn R FarmerAditya BardiaRyan J SullivanSteven M BlumYevgeniy R SemenovAlexandra-Chloé VillaniKerry L ReynoldsPublished in: Journal for immunotherapy of cancer (2022)
This is the first study to report that establishing a highly subspecialized care team focused on irAEs is associated with improved patient outcomes and reduced healthcare utilization. Furthermore, the SIC Service successfully integrated blood and tissue collection safety into routine care.